Industry reports
Editor highlights

Publication dates

All regions

Lymphoma Research Reports, April 2014

You might be interested in: cancer, flow cytometry, hematology, more »


 

1-20 of about 8 900 reports for Lymphoma
The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Or business research. - Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc ...

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... And data relating to the clinical trials on natural killer cell lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe ...

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Relating to the clinical trials on b-cell non-hodgkin lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...

Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014

Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Trials on lymphoblastic lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...

Lymphoma Drug Pathway Analyzer 2014

Lymphoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the lymphoma ...

Lymphoma Drug Pipeline Update 2014

Lymphoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... In 588 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 107 drugs. lymphoma drug pipeline update ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

... For optimizing the leukemia pipeline: from research and development to marketa support tool for optimizing the lymphoma pipeline: from research and development to market ...

Analytical Tool - Lymphoma

Analytical Tool - Lymphoma

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

... Analytical tool - lymphoma executive summary"analytical tool: lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma r ...

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on cutaneous b-cell lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on high grade non-hodgkin lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...


» Read our Company Profiles

16 Companies for Lymphoma

Novartis Inc.

Switzerland

Celgene Corp.

United States

GlaxoSmithKline P.L.C.

United States

Pharmacyclics Inc.

United States

Amgen Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.